Company: JUNS
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001261
Chunk: 410

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 11
Chunk 410
---
 the
time that the Company has raised additional capital from the sale of its securities in the amount of $1,500,000 (the “Reduction
Period”). Upon the expiration of the Reduction Period, the base salary shall be adjusted to be 105% the original base salary.

On
December 17, 2024, the parties agreed that the Company would pay to Titan a monthly fee in the amount of $20,000 (amounting to an aggregate
annual fee of $240,000) for the 2025 calendar year. In addition, Titan is eligible for cash bonuses and additional equity compensation,
at the Company’s discretion.

Elements
of Compensation 

Our
NEOs were provided with the following primary elements of compensation in 2024 and 2023:

Base
Salary

Christer
Rosén and Marshall Hayward received a fixed base salary in an amount determined by the Board of Directors based on a number of
factors, including:

    ●
    The
    nature, responsibilities and duties of the officer’s position;

    ●
    The
    officer’s expertise, demonstrated leadership ability and prior performance;

    ●
    The
    officer’s salary history and total compensation, including annual cash bonuses and long-term incentive compensation; and

108

    ●
    The
    competitiveness of the market for the officer’s services.

See
“—2024 Summary Compensation Table.”

Stock
Option Grants

On
January 1, 2023, the Company granted non-qualified stock option to purchase 562,500 of common stock to Saleem Elmasri, CPA, as Chief
Financial Officer, at an exercise price of $1.33 per share.

On
September 29, 2023, the Company granted non-qualified stock options to purchase 710,344 of common stock to Christer Rosén at an
exercise price of $1.33 per share.

On
September 29, 2023, the Company granted non-qualified stock options to purchase 556,673 of common stock to Marshall Hayward at an exercise
price of $1.33 per share.

On
September 29, 2023, the Company granted non-qualified stock options to purchase 81,600 of common stock to Saleem Elmasri, CPA at an exercise
price of $1.33 per share.

On
December 18, 2023, the Company granted non-qualified stock options to purchase 88,909 of common stock to